Design and test of a pump failure anticipator

Tests were conducted on two different types of pumps in order to refine the concept and to finalize design details of a positive displacement internal gear pump and a shroudless centrifugal pump. A concept and a system that could be used with pumps to allow a rapid judgement to be made of the suitability of the pump for futher service is developed. Test results and detailed data analysis are included

Truncated human endothelin receptor A produced by alternative splicing and its expression in melanoma

In this study, reverse transcriptase polymerase chain reaction was used to amplify human endothelin receptor A (ETA) and ETB receptor mRNA. A truncated ETA receptor transcript with exons 3 and 4 skipped was found. The skipping of these two exons results in 109 amino acids being deleted from the receptor. The truncated receptor was expressed in all tissues and cells examined, but the level of expression varied. In melanoma cell lines and melanoma tissues, the truncated receptor gene was the major species, whereas the wild-type ETA was predominant in other tissues. A 1.9-kb ETA transcript was identified in melanoma cell lines by Northern blot, which was much smaller than the transcript in heart and in other tissues reported previously (4.3 kb). The cDNA coding regions of the truncated and wild-type ETA receptors were stably transfected into Chinese hamster ovary (CHO) cells. The truncated ETA receptor-transfected CHO cells did not show binding affinity to endothelin 1 (ET-1) or endothelin 3 (ET-3). The function and biological significance of this truncated ETA receptor is not clear, but it may have regulatory roles for cell responses to ETs

Future-proofing governance and BIM for owner operators in the UK

Owner operators are managing and maintaining their infrastructure assets. In addition, depending on the national economic activity, they are being reactive or proactive in their response against uncertainty. Findings from this study showed that improvements can be achieved if the concept of future-proofing (FP) of assets – as a structured approach against uncertainty – becomes more explicitly defined. FP is the holistic process of taking security measures against uncertainty and being proactive throughout the organisation and its assets. In combination with information management, it ensures that asset management (AM) strategies will become responsive to a number of future changes in requirements. In this context, it is asserted that both FP and Building Information Modelling (BIM) suffer from a dearth of identification in the context of AM. Through a case study, this paper presents an approach that helps clients to future-proof AM at a strategic level. Furthermore, governance agendas for FP and BIM capabilities for future-proof information have been identified that owner operators and the supply chain can find useful

Comparison of the RNA-amplification based methods RT–PCR and NASBA for the detection of circulating tumour cells

Increasingly, reverse transcriptase polymerase chain reaction (RT–PCR) is used to detect clinically significant tumour cells in blood or bone marrow. This may result in a redefinition of disease-free and clinical relapse. However, its clinical utility may be limited by lack of automation or reproducibility. Recent studies have suggested nucleic acid sequence-based amplification of target RNA may be more robust. In this study, nucleic acid sequence-based amplification was established to detect melanoma, colorectal and prostate cancer cells. Nucleic acid sequence-based amplification and RT–PCR both successfully amplified target RNA in peripheral blood samples from patients with melanoma and colorectal cancer, but only RT–PCR detected PSA in blood samples from patients with prostate cancer. There was relatively good agreement between sample replicates analyzed by RT–PCR (Kappa values of one for tyrosinase, 0.67 for CK-20 and one for PSA), but less agreement when analyzed by nucleic acid sequence-based amplification. This may limit the routine use of NASBA for the detection of clinically significant disease. In summary, RT–PCR appears at present to be the most reliable and reproducible method for the detection of low-level disease in cancer patients, although prospective studies are warranted to assess the clinical utility of different molecular diagnostic methods

Improved methods using the reverse transcriptase polymerase chain reaction to detect tumour cells

Reverse transcriptase polymerase chain reaction (RT-PCR) is increasingly used to detect small numbers of circulating tumour cells, though the clinical benefit remains controversial. The largest single contributing factor to the controversy of its value is the different approaches to sample processing. The aim of this study was to compare the sensitivity and reproducibility of RT-PCR for the detection of tumour cells after four commonly used different methods of sample processing. Using RT-PCR, one tumour cell spiked in 2 ml of whole blood was detected after analysis of separated mononuclear cell RNA, whole blood total or poly-A+RNA. No false positives were identified with any method. However, the reproducibility of tumour cell detection was reduced after isolation of the mononuclear cell fraction. Only analysis of poly-A+RNA had a sensitivity of 100% in all the cell spiking experiments. In patient blood samples, analysis of poly-A+RNA increased the number of blood samples positive for tyrosine hydroxylase (TH) mRNA compared with those positive after analysis of total RNA. This may reflect high levels of cDNA reducing the efficiency of the PCR. Isolation of poly-A+RNA increases the sensitivity and reproducibility of tumour cell detection in peripheral blood. © 1999 Cancer Research Campaig

Controlling fatigue crack paths for crack surface marking and growth investigations

While it is well known that fatigue crack growth in metals that display confined slip, such as high strength aluminium alloys, develop crack paths that are responsive to the loading direction and the local microstructural orientation, it is less well known that such paths are also responsive to the loading history. In these materials, certain loading sequences can produce highly directional slip bands ahead of the crack tip and by adjusting the sequence of loads, distinct fracture surface features or progression marks, even at very small crack depths can result. Investigating the path a crack selects in fatigue testing when particular combinations of constant and variable amplitude load sequences are applied is providing insight into crack growth. Further, it is possible to design load sequences that allow very small amounts of crack growth to be measured, at very small crack sizes, well below the conventional crack growth threshold in the aluminium alloy discussed here. This paper reports on observations of the crack path phenomenon and a novel test loading method for measuring crack growth rates for very small crack depths in aluminium alloy 7050-T7451 (an important aircraft primary structural material). The aim of this work was to firstly generate short- crack constant amplitude growth data and secondly, through the careful manipulation of the applied loading, to achieve a greater understanding of the mechanisms of fatigue crack growth in the material being investigated. A particular focus of this work is the identification of the possible sources of crack growth retardation and closure in these small cracks. Interpreting these results suggests a possible mechanism for why small fatigue crack growth through this material under variable amplitude loading is faster than predicted from models based on constant amplitude data alone

The Unique Impact of COVID-19 on Human Gut Microbiome Research

The coronavirus (COVID-19) pandemic has disrupted clinical trials globally, with unique implications for research into the human gut microbiome. In this mini-review, we explore the direct and indirect influences of the pandemic on the gut microbiome and how these can affect research and clinical trials. We explore the direct bidirectional relationships between the COVID-19 virus and the gut and lung microbiomes. We then consider the significant indirect effects of the pandemic, such as repeated lockdowns, increased hand hygiene, and changes to mood and diet, that could all lead to longstanding changes to the gut microbiome at an individual and a population level. Together, these changes may affect long term microbiome research, both in observational as well as in population studies, requiring urgent attention. Finally, we explore the unique implications for clinical trials using faecal microbiota transplants (FMT), which are increasingly investigated as potential treatments for a range of diseases. The pandemic introduces new barriers to participation in trials, while the direct and indirect effects laid out above can present a confounding factor. This affects recruitment and sample size, as well as study design and statistical analyses. Therefore, the potential impact of the pandemic on gut microbiome research is significant and needs to be specifically addressed by the research community and funders

Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction.

Circulating cancer cells in the blood play a central role in the metastatic process. Their number can be very small and techniques for their detection need to be both sensitive and specific. Polymerase chain reaction (PCR) has been successfully used to detect small numbers of tumour cells in haematological cancer in which abnormalities in DNA are sufficiently consistent to make this possible. For most solid tumours this not yet feasible. However, we have found that reverse transcriptase (RT)-PRC for tissue-specific gene expression is a useful technique for identifying small numbers of circulating cells in melanoma and neuroblastoma patients. In this report we describe detection of colon carcinoma cells by RT-PCR using CK 20 mRNA as a marker. Unlike other cytokeratin genes examined (CK 8 and CK 19), CK 20 was not transcribed in normal haematopoietic cells. This suggests a role for RT-PCR in the detection of colon carcinoma metastasis in blood and bone marrow, using CK 20 as the target gene. Future analysis of clinical material will determine the clinical significance of this technique